×
About 15,157 results

ALLMedicine™ Sarcoidosis Center

Research & Reviews  7,347 results

Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case...
https://doi.org/10.1186/s13256-021-02821-6 10.1097/PAP.0b013e318216b99b 10.1046/j.1442-2050.2000.00140.x 10.1016/S0016-5107(00)70397-X 10.1200/JCO.2016.67.9258 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G 10.1111/1759-7714.13034 10.1056/NEJMoa1709030 10.1158/1078-0432.CCR-13-0739 10.1016/j.ejca.2019.07.001 10.6004/jnccn.2019.0018 10.1056/NEJMoa1412082 10.2217/imt-2018-0011
Journal of Medical Case Reports; Ito S, Tachimori Y et. al.

May 5th, 2021 - Primary malignant melanoma of the esophagus is a rare and aggressive disease that tends to have a poor response to chemotherapies. Previous studies have indicated that currently available treatment for primary malignant melanoma of the esophagus i...

Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sar...
https://doi.org/10.1016/j.jaad.2021.04.079
Journal of the American Academy of Dermatology; Kassamali B, Villa-Ruiz C et. al.

May 3rd, 2021 - Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sarcoidosis.|2021|Kassamali B,Villa-Ruiz C,Kus KJ,Mazori DR,Kassamali AA,|

Clinical Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension.
https://doi.org/10.1016/j.hlc.2021.03.279
Heart, Lung & Circulation; Mathijssen H, Huitema MP et. al.

May 2nd, 2021 - Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis and its aetiology is unclear. Different pathophysiological mechanisms in sarcoidosis-associated pulmonary hypertension (SAPH) are known. Clinical phenotyping can aid clin...

Ichthyosiform sarcoidosis: Report of a case and comprehensive review of the literature.
https://doi.org/10.1111/ijd.15604
International Journal of Dermatology; Chen HW, Vandergriff T

Apr 30th, 2021 - Sarcoidosis is a disease that can affect a multitude of organs and manifest as cutaneous disease. Cutaneous manifestations of sarcoidosis vary widely in morphology, earning the nickname of "great imitator," and the diagnosis often requires clinico...

Whole genome sequencing identifies variants associated with sarcoidosis in a family wit...
https://doi.org/10.1007/s10067-021-05684-w 10.1016/S0140-6736(13)60680-7 10.1186/s12883-016-0741-x 10.1111/cei.12138 10.1016/j.ccm.2015.08.002 10.1136/thx.2007.094060 10.4161/fly.19695 10.1016/S1877-1173(15)00122-2 10.1182/blood.V97.3.785 10.1007/s12016-016-8538-7 10.1084/jem.175.1.121 10.1182/bloodadvances.2018023184 10.1056/NEJMra1100030 10.1073/pnas.1205526109 10.1097/MOL.0000000000000060 10.1146/annurev-physiol-021014-071931 10.1038/72793 10.1016/S0960-8966(00)00150-4 10.1038/nature12807 10.1111/bjd.16832 10.1016/j.immuni.2018.04.004 10.1016/j.tcb.2005.11.004 10.1261/rna.051524.115 10.1210/jc.2010-0023 10.1038/ng.717 10.1038/ng.3782 10.1136/thx.48.12.1230 10.1164/ajrccm/143.1.53 10.1038/cti.2016.75 10.1038/s41598-017-04109-6 10.1183/09031936.00049410 10.1038/ng.3755 10.2147/CEG.S150908 10.1056/NEJMoa1805958 10.1038/nature12199 10.1542/peds.2005-1349 10.1073/pnas.0403831101 10.3389/fimmu.2013.00295 10.1165/rcmb.2016-0035OC 10.1007/s12016-015-8481-z 10.1164/ajrccm.156.5.9704069 10.1086/507847 10.1164/ajrccm.162.3.9901099 10.1186/s12920-018-0338-x 10.1007/s00439-018-1915-y 10.1038/nature15393
Clinical Rheumatology; Fritz D, Ferwerda B et. al.

Apr 27th, 2021 - We studied genetic risk factors associated with sarcoidosis within a family with a high prevalence of this disease. We studied 41 members of a family with a high rate of sarcoidosis, including an index patient with treatment-resistant neurosarcoid...

see more →

Guidelines  3 results

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159433
American Journal of Respiratory and Critical Care Medicine; Crouser ED, Maier LA et. al.

Apr 15th, 2020 - Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternativ...

2019 HRS expert consensus statement on evaluation, risk stratification, and management ...
https://doi.org/10.1016/j.hrthm.2019.05.007
Heart Rhythm; Towbin JA, McKenna WJ et. al.

May 12th, 2019 - Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders....

Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for c...
https://doi.org/10.1007/s12149-014-0806-0
Annals of Nuclear Medicine; Ishida Y, Yoshinaga K et. al.

Jan 27th, 2014 - Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.|2014|Ishida Y,Yoshinaga K,Miyagawa M,Moroi M,Kondoh C,|diagnostic imaging,diagnostic...

see more →

Clinicaltrials.gov  7,503 results

Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case...
https://doi.org/10.1186/s13256-021-02821-6 10.1097/PAP.0b013e318216b99b 10.1046/j.1442-2050.2000.00140.x 10.1016/S0016-5107(00)70397-X 10.1200/JCO.2016.67.9258 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G 10.1111/1759-7714.13034 10.1056/NEJMoa1709030 10.1158/1078-0432.CCR-13-0739 10.1016/j.ejca.2019.07.001 10.6004/jnccn.2019.0018 10.1056/NEJMoa1412082 10.2217/imt-2018-0011
Journal of Medical Case Reports; Ito S, Tachimori Y et. al.

May 5th, 2021 - Primary malignant melanoma of the esophagus is a rare and aggressive disease that tends to have a poor response to chemotherapies. Previous studies have indicated that currently available treatment for primary malignant melanoma of the esophagus i...

Tofacitinib: Small Study Shows Big Cutaneous Sarcoidosis Response
https://www.medscape.com/viewarticle/950598

May 4th, 2021 - Researchers are reporting impressive results in a small, open-label trial of the JAK inhibitor tofacitinib in cutaneous sarcoidosis: 6 of 10 patients improved so much that they reached a disease activity level of zero, and all patients improved by...

Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sar...
https://doi.org/10.1016/j.jaad.2021.04.079
Journal of the American Academy of Dermatology; Kassamali B, Villa-Ruiz C et. al.

May 3rd, 2021 - Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sarcoidosis.|2021|Kassamali B,Villa-Ruiz C,Kus KJ,Mazori DR,Kassamali AA,|

Clinical Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension.
https://doi.org/10.1016/j.hlc.2021.03.279
Heart, Lung & Circulation; Mathijssen H, Huitema MP et. al.

May 2nd, 2021 - Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis and its aetiology is unclear. Different pathophysiological mechanisms in sarcoidosis-associated pulmonary hypertension (SAPH) are known. Clinical phenotyping can aid clin...

Ichthyosiform sarcoidosis: Report of a case and comprehensive review of the literature.
https://doi.org/10.1111/ijd.15604
International Journal of Dermatology; Chen HW, Vandergriff T

Apr 30th, 2021 - Sarcoidosis is a disease that can affect a multitude of organs and manifest as cutaneous disease. Cutaneous manifestations of sarcoidosis vary widely in morphology, earning the nickname of "great imitator," and the diagnosis often requires clinico...

see more →

News  281 results

Tofacitinib: Small Study Shows Big Cutaneous Sarcoidosis Response
https://www.medscape.com/viewarticle/950598

May 4th, 2021 - Researchers are reporting impressive results in a small, open-label trial of the JAK inhibitor tofacitinib in cutaneous sarcoidosis: 6 of 10 patients improved so much that they reached a disease activity level of zero, and all patients improved by...

Suspect Sarcoidosis? Here's What to Assess
https://www.medscape.com/viewarticle/948848

Apr 27th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: We are back. This is The Curbsiders. I'm Dr Matthew Watto, here with my good friend, Dr Paul Williams. We're going to talk about sarcoidosis. We had a wonderful conversation with t...

Black Patients With Cutaneous Sarcoidosis May Have More Systemic and CV Disease
https://www.medscape.com/viewarticle/949418

Apr 15th, 2021 - Black patients diagnosed by dermatologists with cutaneous sarcoidosis were significantly more likely to have unrecognized systemic organ involvement than were non-Black patients, according to a retrospective chart review of patients seen at Massac...

Fast Five Quiz: Tattoos
https://reference.medscape.com/viewarticle/936721_5

Sep 9th, 2020 - Answer 4/5 Which of the following is most accurate regarding the treatment of tattoo reactions? Your peers chose: If an allergic reaction to tattoo ink is noted, removal with a Q-switched laser is recommended 0% Allopurinol is a treatment option f...

Sarcoidosis May Raise Long-term Risk of Heart Failure and Death
https://www.medscape.com/viewarticle/935573

Aug 11th, 2020 - Patients with sarcoidosis have an increased risk of heart failure and other adverse outcomes, including all-cause mortality, according to a decade-long nationwide study of Danish patients with the inflammatory disease. "Although these findings are...

see more →

Patient Education  23 results see all →